Cyclin A2

From WikiMD's Wellness Encyclopedia

Cyclin A2[edit | edit source]

Cyclin A2 is a member of the cyclin family, which is a group of proteins that are crucial regulators of the cell cycle. Cyclin A2 is involved in the control of the cell cycle at two critical points: the S phase and the G2/M transition. It is encoded by the CCNA2 gene in humans.

Structure[edit | edit source]

Cyclin A2 is a protein that contains a conserved region known as the cyclin box, which is responsible for its interaction with cyclin-dependent kinases (CDKs). The protein structure allows it to bind to CDK1 and CDK2, forming active complexes that are essential for cell cycle progression.

Function[edit | edit source]

Cyclin A2 plays a dual role in the cell cycle:

  • S Phase: Cyclin A2 binds to CDK2, forming a complex that is necessary for the initiation and progression of DNA replication. This complex phosphorylates various substrates that are involved in the replication machinery.
  • G2/M Transition: Cyclin A2 also associates with CDK1, facilitating the transition from the G2 phase to mitosis. This complex is involved in the activation of proteins required for mitotic entry.

Regulation[edit | edit source]

The expression and activity of Cyclin A2 are tightly regulated throughout the cell cycle. Cyclin A2 levels are low in the G1 phase, increase during the S phase, and peak in the G2 phase. The degradation of Cyclin A2 is mediated by the anaphase-promoting complex/cyclosome (APC/C), which targets it for ubiquitination and subsequent proteasomal degradation.

Clinical Significance[edit | edit source]

Abnormal regulation of Cyclin A2 has been implicated in various cancers. Overexpression of Cyclin A2 can lead to uncontrolled cell proliferation, a hallmark of cancer. Studies have shown that Cyclin A2 is overexpressed in several types of tumors, including breast, lung, and colorectal cancers.

Research[edit | edit source]

Research on Cyclin A2 continues to explore its role in cancer biology and its potential as a therapeutic target. Inhibitors of Cyclin A2-CDK complexes are being investigated for their ability to halt the proliferation of cancer cells.

See Also[edit | edit source]

References[edit | edit source]

  • Sherr, C. J. (1996). "Cancer cell cycles." Science, 274(5293), 1672-1677.
  • Pagano, M., & Draetta, G. (1992). "Cyclin A is required at two points in the human cell cycle." The EMBO Journal, 11(3), 961-971.

External Links[edit | edit source]

Contributors: Prab R. Tumpati, MD